Metabolic reprogramming by caloric restriction enhances acute phase virological control and reduces chronic inflammation in SIV-infected rhesus macaques

Caloric restriction in SIV-infected rhesus macaques enhances acute viral control through metabolic reprogramming and reduces chronic inflammation during antiretroviral therapy, although it does not eliminate viral persistence.

The Gist

The Big Picture: Starving the Virus, Feeding the Immune System?

Imagine your body is a bustling city under attack by a sneaky burglar (the virus, SIV, which is very similar to HIV in humans). Usually, the police (your immune system) are exhausted, the city is on fire (chronic inflammation), and the burglar keeps stealing.

Scientists wanted to know: What if we changed the city's power supply? Specifically, what happens if we put the city on a "diet" (Caloric Restriction) to see if it helps the police fight the burglar better?

This study took a group of healthy monkeys, put half of them on a strict 30% calorie diet for four months, and then infected them with the virus. They found that the dieting monkeys handled the infection much better than the ones who ate as much as they wanted.

---

Phase 1: The Diet (Caloric Restriction)

The Analogy: Think of the monkeys' bodies as cars. The "Ad Libitum" group (eating as much as they want) is driving with the gas pedal floored, burning fuel constantly. The "Caloric Restriction" (CR) group is driving with a strict fuel limit.

• The Result: The dieting monkeys lost a little weight (like a car getting lighter), but they didn't break down. Their engines (metabolism) actually became more efficient. They weren't stressed out; they were just running leaner.

Phase 2: The Attack (Acute Infection)

When the virus hit, the two groups reacted very differently.

1. The "Sugar Rush" Defense

• What happened: The dieting monkeys suddenly switched their immune cells to run on sugar (glycolysis) at a super-fast speed.
• The Analogy: Imagine the immune cells are race cars. The dieting monkeys gave their race cars a massive nitrous oxide boost. They burned sugar rapidly to generate energy.
• The Effect: This sugar-fueled explosion allowed the immune system to multiply its "police force" (T-cells) incredibly fast. Because the police were so active and numerous, they kept the virus count (viremia) lower during the first few weeks of the infection.
• The Catch: This sugar rush is like a sprint. It's powerful but short-lived. Eventually, the dieting monkeys' sugar-fueled defense slowed down, and the virus levels started to creep back up. You can't sprint a marathon forever.

2. The "Traffic Jam" Avoidance

• What happened: The dieting monkeys had fewer "target cells" (the specific cells the virus likes to infect) in their gut.
• The Analogy: The virus is a burglar looking for a specific type of house to break into. The dieting monkeys had fewer of those specific houses available in their gut. The burglar had a harder time finding a place to hide and multiply, so the initial crime wave was smaller.

3. The "Panic Button" Wasn't Pressed

• What happened: In a normal infection, the body screams "PANIC!" (Type I Interferon response), which actually stops the police from multiplying because they get too stressed.
• The Analogy: Because the dieting monkeys had fewer viruses initially, they didn't hit the panic button as hard. This meant their police force (CD8+ T cells) could keep working and multiplying without getting exhausted.

Phase 3: The Long Haul (Chronic Infection & Treatment)

After the initial attack, the monkeys were put on medication (ART) to stop the virus. This is like putting a fence around the city to keep the burglar locked up.

1. The Gut Repair Crew

• What happened: Even with the virus locked up, the "eating as much as they want" group still had a damaged gut and high inflammation. The dieting group, however, had a much healthier gut.
• The Analogy: The dieting monkeys' gut was like a well-maintained garden. The other group's gut was like a muddy, trampled field. The dieting monkeys had a better "TCA cycle" (a metabolic engine) running in their gut cells, which helped repair the tissue and stop the "leakage" of bad bacteria into the blood.

2. The Inflammation Fire

• What happened: The dieting monkeys had much lower levels of "smoke" (inflammatory markers) in their blood.
• The Analogy: The non-dieting group was still coughing up smoke even though the fire was out. The dieting group's city was clean and quiet. This is huge because chronic inflammation is what causes heart disease and other problems in people with HIV.

3. The Surprise: The Virus Didn't Disappear

• The Twist: Even though the dieting monkeys had less inflammation and a healthier gut, the amount of hidden virus (the reservoir) in their blood and tissues was exactly the same as the non-dieting group.
• The Analogy: The diet fixed the city's streets and reduced the smoke, but it didn't find the burglar's secret hideout. The burglar was still hiding in the basement, just as many of him as before. This suggests that while diet fixes the damage caused by the virus, it doesn't necessarily cure the virus or make the hidden virus go away.

The Takeaway

What does this mean for us?

1. Diet is a powerful tool: Changing what you eat can change how your body fights viruses. It's not just about weight; it's about rewiring your immune system's engine.
2. Timing matters: The "sugar rush" defense worked great for the start of the infection but faded away. This teaches us that the body needs different energy strategies for different stages of a battle.
3. Inflammation vs. Cure: You can have a very healthy, low-inflammation body and still carry the virus. Fixing the inflammation is great for your long-term health (preventing heart attacks, etc.), but it doesn't automatically mean you are cured of the infection.

In short: Putting the body on a "diet" helped the monkeys fight the initial infection better and recover their gut health, but it didn't kick the virus out of the house entirely. It's a powerful way to manage the disease, even if it's not a magic cure.

Technical Summary

1. Problem Statement

Despite the success of antiretroviral therapy (ART) in suppressing HIV-1 replication, persons with HIV (PWH) suffer from residual pathologies, including chronic inflammation, gastrointestinal (GI) tract dysfunction, and immune exhaustion. These conditions are driven by dysregulated cellular metabolism (e.g., a shift toward glycolysis and away from oxidative phosphorylation). While therapeutic strategies targeting specific metabolic pathways have faced toxicity hurdles, nutritional interventions like Caloric Restriction (CR) offer a safer, pleiotropic approach. However, the impact of CR on lentiviral infection outcomes in higher-order mammals (non-human primates) remains largely unexplored. This study investigates whether modulating diet can improve virologic control and reduce chronic inflammation in an SIV-infected rhesus macaque model.

2. Methodology

• Study Design & Cohort:
  • Subjects: 17 adult, non-obese Indian-origin rhesus macaques (male and female).
  • Groups: Animals were divided into an Ad Libitum (AL) control group and a Caloric Restriction (CR) group.
  • Intervention:
    • Phase 1 (Conditioning): 2 months of Time-Restricted (TR) feeding (8:00–16:00) to acclimate animals.
    • Phase 2 (CR): CR group received 30% fewer calories than their baseline AL intake within the TR window for 4 months prior to infection.
    • Infection: Both groups were infected with 5,000 infectious units of a barcoded SIVmac239M clone via intravenous injection.
    • Treatment: At 28 days post-infection (dpi), all animals initiated a suppressive ART regimen (Tenofovir, Emtricitabine, Dolutegravir) and continued for 11 months.
• Data Collection & Analysis:
  • Virology: Plasma viral load (VL) quantification, SIV DNA reservoir measurement in blood and tissues, and barcode sequencing to track viral strain diversity.
  • Immunology: Flow cytometry for T cell phenotypes (activation, proliferation, exhaustion markers), cytokine profiling (Olink® panel), and tissue histology (H&E, MPO staining).
  • Metabolomics: Untargeted LC-MS plasma metabolomics and Seahorse XF Glycolytic Stress Tests on PBMCs to measure glycolytic flux and TCA cycle activity.
  • Safety: Monitoring of body weight, body condition scores (BCS), blood chemistry, and stress hormones (corticosteroids).

3. Key Contributions

• First Primate Model of CR in Lentiviral Infection: Demonstrates that CR is safe and feasible in non-human primates, inducing metabolic reprogramming without malnutrition or excessive stress.
• Temporal Dichotomy of Glycolysis: Reveals that while glycolysis is typically associated with chronic inflammation and exhaustion in HIV, CR-induced glycolytic skewing provides a transient protective benefit during acute infection.
• Decoupling Inflammation from Reservoir Size: Shows that while CR significantly reduces systemic inflammation and gut immune activation during ART, it does not reduce the size of the viral reservoir, suggesting these two pathologies are driven by distinct mechanisms.
• Metabolic Phase-Dependent Shifts: Identifies a shift from a glycolytic-dominant state during acute infection to a TCA-cycle-dominant state during chronic ART suppression in CR animals.

4. Key Results

A. Safety and Metabolic Reprogramming

• CR resulted in modest weight loss but maintained normal blood glucose, lipid profiles, and liver/kidney function.
• Corticosteroid levels were unchanged, indicating the diet did not induce a stress response.
• Pre-infection, CR animals showed reduced frequencies of target CCR5+ CD4+ T cells specifically in the gut mucosa.

B. Acute Phase SIV Infection (0–28 dpi)

• Virologic Control: CR animals exhibited significantly lower peak viremia (14–21 dpi) compared to AL controls (~1 log10 reduction in Area Under Curve). However, this protection waned by 28 dpi.
• Mechanism of Protection:
  • The reduction in viremia correlated with the pre-infection reduction of gut target cells (CCR5+ CD4+).
  • CR animals had lower plasma IFN-α levels, which paradoxically allowed for increased proliferation (Ki-67+) of CD8+ T cells and NK cells in lymphoid tissues (reduced anti-proliferative effect of high IFN-α).
  • Metabolic Signature: CR induced a robust upregulation of glycolysis (elevated lactate, G6P, DHAP) and mTOR pathway activation (pS6) in T cells. High glycolytic metabolites inversely correlated with peak viral load.
  • Viral Diversity: Barcode sequencing showed no selective pruning of viral lineages; the protection was a global "scaling down" of replication rather than immune selection of specific strains.

C. Chronic Phase (ART Suppression, 11 months)

• Inflammation & Gut Health: CR significantly reduced systemic inflammation markers (sCD14, TNF family cytokines, CXCL9) and gut immune activation.
  • Histology showed reduced lymphocytic infiltration in the colon.
  • CR colonic CD4+ T cells were less activated and skewed toward a tolerogenic phenotype (Tregs/Tfh) compared to the Th1-skewed, activated cells in AL animals.
• Metabolic Shift: Unlike the acute phase, CR animals on ART showed elevated TCA cycle metabolites and bile acids, suggesting improved mitochondrial function and gut epithelial repair.
• Viral Reservoir: Despite reduced inflammation, total SIV DNA levels in blood and tissues were unchanged between CR and AL groups. This indicates that the inflammatory mediators mitigated by CR do not drive the persistence of the viral reservoir in this model.
• Cellular Dynamics: CR animals had lower circulating T cell counts but higher retention of memory T cells and monocytes in the bone marrow, suggesting a "safe haven" effect.

5. Significance

• Therapeutic Potential: The study validates diet as a potent modulator of HIV/SIV pathogenesis. CR can improve acute viral control and mitigate the chronic inflammatory "burnout" associated with long-term ART.
• Immunometabolic Insight: It challenges the monolithic view of glycolysis in HIV. While chronic glycolysis is detrimental, an acute, diet-induced glycolytic surge can support rapid immune expansion and viral control. Conversely, the transition to oxidative metabolism (TCA cycle) during ART appears crucial for resolving chronic inflammation and repairing the gut.
• Cure Research Implications: The finding that reduced inflammation does not equate to a smaller viral reservoir suggests that anti-inflammatory strategies alone may be insufficient for HIV cure. Reservoir persistence appears independent of the specific inflammatory profile mitigated by CR.
• Clinical Translation: The study supports the investigation of nutritional interventions (or pharmacological mimetics like incretin mimetics) as adjunctive therapies to manage comorbidities and inflammation in PWH, though the transient nature of acute protection suggests timing and context are critical.

Limitations Noted: The study did not include an ART interruption (ATI) to test viral rebound; CR was implemented preventively (before infection), so therapeutic efficacy in established disease is unknown; and the study combined time-restricted feeding with caloric restriction, making it difficult to isolate the specific contribution of time restriction alone.